Kardiochirurgia i Torakochirurgia Polska

Abstract

1/2025 vol. 22
Review paper

Perioperative glycemic control in patients undergoing cardiac surgery

  1. Department of Anesthesiology and Intensive Care, School of Medicine, Medical University of Silesia, Katowice, Poland
  2. Department of Cardiac Anesthesiology and Intensive Care, Silesian Center for Heart Diseases, Zabrze, Poland
  3. Department of Acute Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
Kardiochirurgia i Torakochirurgia Polska 2025; 22 (1): 44-52
Online publish date: 2025/03/17
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Diabetes mellitus (DM) is one of the most common chronic diseases, affecting globally about 537 million adults. Cardiovascular disease remains the leading cause of death and medical emergencies in the DM patient population. As a result, about 40% of patients with DM undergo cardiac surgery, mainly in the coronary arteries. Uncontrolled hyperglycemia, especially the prolonged condition, is an independent factor in postoperative mortality and the cause of many serious complications, such as surgical wound infection, sepsis, renal failure or cerebral or cardiovascular incidents. Adequate glycemic control in the perioperative period is the most important way to prevent the above complications. The issue has remained an important topic of many observational and experimental studies for years. This paper summarizes the current knowledge with regard to strategies of hyperglycemic control in patients undergoing cardiac surgery.
Share
without publication fees
without publication fees